ABOUT US
BHI BIOLOGICS
Biological products often represent the forefront of biomedical research and, in time, may offer the most effective means to treat a variety of medical illnesses and conditions that presently have no other treatments available.
With nearly 15 years of stem cell therapy experience, our published research illustrates promising results. Our team was the first to publish a safety study on cultured Wharton’s jelly mesenchymal stem cell therapy used on patients in 2017 at our Jamaica clinic.
Our many years of experience and our favorable results with regenerative medicine have led us to produce the highest quality stem cells, exosomes/extracellular vesicles, and other available biologics available anywhere across the globe.
We bring the expertise of BHI Therapeutic Sciences and the more than 100 protocols our team of scientists have submitted to the FDA. Our model mirrors the Blue Horizon International clinics around the world.
WHAT WE DO
BHI BIOLOGICS
BHI Biologics supplies stem cells and exosomes to physicians and
regenerative medicine clinics across the globe. Products are not
available for purchase by individual patients, but our medical team can
collaborate with providers to make the therapeutics available to a
licensed physician and clinic in their location.